IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
165.62
-3.74 (-2.21%)
Feb 20, 2026, 4:00 PM EST - Market closed
IQVIA Holdings Revenue
In the year 2025, IQVIA Holdings had annual revenue of $16.31B with 5.87% growth. IQVIA Holdings had revenue of $4.36B in the quarter ending December 31, 2025, with 10.26% growth.
Revenue (ttm)
$16.31B
Revenue Growth
+5.87%
P/S Ratio
1.72
Revenue / Employee
$175,376
Employees
93,000
Market Cap
28.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.31B | 905.00M | 5.87% |
| Dec 31, 2024 | 15.41B | 421.00M | 2.81% |
| Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
| Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
| Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
| Dec 31, 2020 | 11.36B | 271.00M | 2.44% |
| Dec 31, 2019 | 11.09B | 676.00M | 6.49% |
| Dec 31, 2018 | 10.41B | 710.00M | 7.32% |
| Dec 31, 2017 | 9.70B | 2.89B | 42.36% |
| Dec 31, 2016 | 6.82B | 1.08B | 18.79% |
| Dec 31, 2015 | 5.74B | 277.00M | 5.07% |
| Dec 31, 2014 | 5.46B | 360.46M | 7.07% |
| Dec 31, 2013 | 5.10B | 234.03M | 4.81% |
| Dec 31, 2012 | 4.87B | 537.77M | 12.43% |
| Dec 31, 2011 | 4.33B | 403.73M | 10.29% |
| Dec 31, 2010 | 3.92B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.04B |
| Agilent Technologies | 6.95B |
| Illumina | 4.34B |
| IDEXX Laboratories | 4.30B |
| Mettler-Toledo International | 4.03B |
| Exact Sciences | 3.25B |
| Waters | 3.17B |
IQV News
- 2 days ago - IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day - Business Wire
- 8 days ago - Oakmark Global All Cap Strategy Q4 2025 Performance Review - Seeking Alpha
- 10 days ago - IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions - Business Wire
- 15 days ago - IQVIA Holdings Inc. (IQV) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - IQVIA forecasts weak annual profit on higher interest expenses - Reuters
- 15 days ago - IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance - Business Wire
- 22 days ago - IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration - Business Wire
- 4 weeks ago - IQVIA Named to the Fortune® World's Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year - Business Wire